Page last updated: 2024-08-17

17-alpha-hydroxyprogesterone and Abnormalities, Urogenital

17-alpha-hydroxyprogesterone has been researched along with Abnormalities, Urogenital in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Abdalla, A; Dotters-Katz, SK; Hynes, JS; Manuck, TA; Schwartz, AR1
Choi, JH; Kim, GH; Kim, YM; Ko, JM; Seo, GH; Yoo, HW1

Other Studies

2 other study(ies) available for 17-alpha-hydroxyprogesterone and Abnormalities, Urogenital

ArticleYear
17-hydroxyprogesterone caproate for women with congenital uterine anomalies: does it impact the risk of recurrent preterm birth?
    American journal of obstetrics & gynecology MFM, 2021, Volume: 3, Issue:1

    Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Female; Humans; Infant, Newborn; Pregnancy; Premature Birth; Urogenital Abnormalities; Uterus

2021
A case of an infant suspected as IMAGE syndrome who were finally diagnosed with MIRAGE syndrome by targeted Mendelian exome sequencing.
    BMC medical genetics, 2018, 03-05, Volume: 19, Issue:1

    Topics: 17-alpha-Hydroxyprogesterone; Adrenal Insufficiency; Adrenocorticotropic Hormone; Asian People; Cryptorchidism; Cyclin-Dependent Kinase Inhibitor p57; Exome Sequencing; Exons; Fetal Growth Retardation; Genital Diseases, Male; Humans; Hydrocortisone; Infant, Newborn; Intracellular Signaling Peptides and Proteins; Male; Mutation; Osteochondrodysplasias; Penis; Proteins; Renin; Urogenital Abnormalities

2018